RxDoctor Payments Data

Joe Dib, MD

Emergency Medicine · Holmdel, NJNPI 1700820933

Payments from drug & device makers

$1,106in general payments, 2019–2025

Across 40 payments — averaging $27.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$458
  • Johnson & Johnson$197
  • Boehringer Ingelheim$110
  • Regeneron Healthcare Solutions, Inc.$108
  • AstraZeneca$88
  • Pfizer$47
  • plus $99 from 4 others

What the payments were for

  • Food & beverage$1,106100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)18$458
Johnson & Johnson6$197
Boehringer Ingelheim1$110
Regeneron Healthcare Solutions, Inc.1$108
AstraZeneca(2 entities)6$88
Pfizer3$47
Vapotherm Inc1$30
Gilead2$28
Stryker1$27
Merck1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,106 in reported general payments places this provider in the 90th percentile of 1,505 emergency medicine providers in New Jersey.

See all emergency medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$35,528
Medicare patients
185
Services billed
258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefdinir23$376
Levofloxacin33$204
Ondansetron OdtOndansetron23$178
Cephalexin17$127
Naproxen39$121
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$95
Ciprofloxacin Hcl18$80
Diclofenac Sodium18$73
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$59
Prednisone27$55
Azithromycin12$36

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Holmdel

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →